NDC 13985-613 - Ostilox
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-613
- Package NDCs from labels
- 13985-613-10, 13985-613-32, 13985-613-01
- Manufacturer
- MWI/VetOne | Norbrook Laboratories Limited
- Effective date
- 2025-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ostilox - MWI/VetOne | Norbrook Laboratories Limited | MWI/VetOne | Norbrook Laboratories Limited | 2025-03-03 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-613-01 | Ostilox | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-613-01 | Ostilox | 100 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 100 | 7 | |
| 13985-613-10 | Ostilox | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-613-10 | Ostilox | 10 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 10 | 7 | |
| 13985-613-32 | Ostilox | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-613-32 | Ostilox | 32 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 32 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| meloxicam | ACTIVE INGREDIENT | VG2QF83CGL | OSTILOX (MELOXICAM) SUSPENSION [MWI/VETONE] | 1 | |
| meloxicam | ACTIVE MOIETY | VG2QF83CGL | OSTILOX (MELOXICAM) SUSPENSION [MWI/VETONE] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445dc4f6-daac-e2f1-e063-6394a90a0ca5 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 453c5328-090e-0159-e063-6394a90a06b7 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445d7cbf-bd3e-a54f-e063-6294a90a67a5 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 7895f389-1509-4e03-8668-526ab1627fc8 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 2322a070-25f0-4fc6-a98e-44ad1fb52dc5 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| SYMBRAVO | MELOXICAM, RIZATRIPTAN | Axsome Therapeutics, Inc. | dcf1ecd1-08a0-8e47-e053-2a95a90abdc7 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Redpharm Drug | 58d34e5d-4efb-3d76-e063-6394a90aa0f6 | 2026-10-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Zybic | MELOXICAM | Redmont Pharmaceuticals, LLC | a1c2d65f-ebb1-48bf-8fa1-c216f7d570ec | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | 597406 VG2QF83CGL |
| Meloxicam | MELOXICAM | Avondale Pharmaceuticals, LLC | 4ddf5a4d-8e84-419d-8e3a-c91b85501885 | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | 597406 VG2QF83CGL |
| Meloxicam | MELOXICAM | Direct_Rx | 58dcbc65-d126-7b48-e063-6294a90a52e9 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | REMEDYREPACK INC. | 385b7cf4-976a-4a58-9ebc-def8b6e78b75 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | REMEDYREPACK INC. | cdd282df-572f-42a7-a1c6-a00e1bb4573d | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Sportpharm LLC | f210e6b4-43b3-4d33-bc0b-013a0f907d3e | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Direct_Rx | 58dbce26-b2ac-2ce4-e063-6294a90a5727 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | REMEDYREPACK INC. | 7048d6cc-88a7-4743-8481-63a2005fa27a | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | REMEDYREPACK INC. | f8c35ea4-d6ac-40c7-8f35-864fd1ec75d2 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 5488ccc1-e416-e5d7-e063-6294a90a6cb8 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 548ec3b7-2b6d-cd9e-e063-6394a90a78ff | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 548ef3ed-ab67-ec85-e063-6294a90ab1da | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| QAMZOVA | MELOXICAM | Nanjing Delova Biotech Co., Ltd. | 385fd779-1be1-49ae-8213-750b96ecc997 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.